The $30 million, NIH Phase 3 Trial to Assess Chelation Therapy (TACT) exposes subjects to a risky method that is known to be ineffective. The TACT should be abandoned and its origins investigated. The Medscape Journal of Medicine
Dr. Jeffrey Lieberman discusses the worsening shortage of psychiatric resources and how our population?s future mental health needs can be met. Medscape Psychiatry & Mental Health
Primary care practices are more likely to qualify as medical homes, but 40% of them still do not make the grade, according to a new study. Medscape Medical News
Physicians should allow patients to choose whether they want ventricular assist device support or not, a Mayo Clinic-led ethics review concludes. Heartwire
A total of 13 additional human embryonic stem cell lines have been approved for federal funding and added to the National Institutes of Health Stem Cell Registry. Medscape Medical News
